Drug Import Replacement Is a Perspective Direction of the Development of Russian Economy

K. D. Grigorieva ()

Administrative Consulting, 2018, issue 5

Abstract: The development of the domestic pharmaceutical industry as a science-intensive and hightech sector of the country’s economy is, among other things, a pledge of the drug safety of the state, especially in the conditions of a modern complex political situation and the sanctions regime. Solving related issues requires an integrated approach, active interaction of the state and participants in the pharmaceutical production and marketing market, a systemic approach and coordination of efforts to implement drug import substitution in the country, creating conditions for increasing the innovative activity of pharmaceutical companies. The main tendencies and directions of the industry development are considered in the article, the data on the course of drug import substitution in Russia are given.

Date: 2018
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.acjournal.ru/jour/article/viewFile/865/860 (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:acf:journl:y:2018:id:865

DOI: 10.22394/1726-1139-2018-5-137-142

Access Statistics for this article

More articles in Administrative Consulting from Russian Presidential Academy of National Economy and Public Administration. North-West Institute of Management.
Bibliographic data for series maintained by ().